Vertex Pharmaceuticals
VRTX
#155
Rank
NZ$239.60 B
Marketcap
NZ$945.05
Share price
-2.94%
Change (1 day)
26.02%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): NZ$27.38

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$28.44. In 2025 the company made an earnings per share (EPS) of NZ$28.08 an increase over its 2024 EPS that were of NZ-$3.74.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$27.38-2.5%
2025NZ$28.08-850.97%
2024NZ-$3.74-114.67%
2023NZ$25.488.17%
2022NZ$23.5642.64%
2021NZ$16.52-12.67%
2020NZ$18.91128.01%
2019NZ$8.30-44.54%
2018NZ$14.96670.09%
2017NZ$1.94-327.66%
2016NZ-$0.85-79.65%
2015NZ-$4.19-26.43%
2014NZ-$5.7053.92%
2013NZ-$3.70316.33%
2012NZ-$0.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.12-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.62-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.63-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.80-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.20-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ-$4.37-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA